464 related articles for article (PubMed ID: 29953886)
1. (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray.
Chou D; Peng HY; Lin TB; Lai CY; Hsieh MC; Wen YC; Lee AS; Wang HH; Yang PS; Chen GD; Ho YC
Neuropharmacology; 2018 Sep; 139():1-12. PubMed ID: 29953886
[TBL] [Abstract][Full Text] [Related]
2. Ketamine metabolite (2R,6R)-hydroxynorketamine enhances aggression via periaqueductal gray glutamatergic transmission.
Ye L; Ko CY; Huang Y; Zheng C; Zheng Y; Chou D
Neuropharmacology; 2019 Oct; 157():107667. PubMed ID: 31207251
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor in the ventrolateral periaqueductal gray contributes to (2R,6R)-hydroxynorketamine-mediated actions.
Chou D
Neuropharmacology; 2020 Jun; 170():108068. PubMed ID: 32222405
[TBL] [Abstract][Full Text] [Related]
4. Periaqueductal gray is required for controlling chronic stress-induced depression-like behavior.
Peng WH; Kan HW; Ho YC
Biochem Biophys Res Commun; 2022 Feb; 593():28-34. PubMed ID: 35051779
[TBL] [Abstract][Full Text] [Related]
5. Periaqueductal Gray Glutamatergic Transmission Governs Chronic Stress-Induced Depression.
Ho YC; Lin TB; Hsieh MC; Lai CY; Chou D; Chau YP; Chen GD; Peng HY
Neuropsychopharmacology; 2018 Jan; 43(2):302-312. PubMed ID: 28853438
[TBL] [Abstract][Full Text] [Related]
6. (2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism.
Riggs LM; Aracava Y; Zanos P; Fischell J; Albuquerque EX; Pereira EFR; Thompson SM; Gould TD
Neuropsychopharmacology; 2020 Jan; 45(2):426-436. PubMed ID: 31216563
[TBL] [Abstract][Full Text] [Related]
7. NMDA receptor partial agonist GLYX-13 alleviates chronic stress-induced depression-like behavior through enhancement of AMPA receptor function in the periaqueductal gray.
Yang PS; Peng HY; Lin TB; Hsieh MC; Lai CY; Lee AS; Wang HH; Ho YC
Neuropharmacology; 2020 Nov; 178():108269. PubMed ID: 32791085
[TBL] [Abstract][Full Text] [Related]
8. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
[TBL] [Abstract][Full Text] [Related]
9. Prelimbic cortex miR-34a contributes to (2R,6R)-hydroxynorketamine-mediated antidepressant-relevant actions.
Ye L; Xiao X; Xu Y; Zheng C; Chen S; Luo T; Li Z; Du Y; Yuan Y; Li L; Liu B; Qin W; Chou D
Neuropharmacology; 2022 May; 208():108984. PubMed ID: 35131296
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant-relevant concentrations of the ketamine metabolite (2
Lumsden EW; Troppoli TA; Myers SJ; Zanos P; Aracava Y; Kehr J; Lovett J; Kim S; Wang FH; Schmidt S; Jenne CE; Yuan P; Morris PJ; Thomas CJ; Zarate CA; Moaddel R; Traynelis SF; Pereira EFR; Thompson SM; Albuquerque EX; Gould TD
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5160-5169. PubMed ID: 30796190
[TBL] [Abstract][Full Text] [Related]
11. BDNF-TrkB signaling-mediated upregulation of Narp is involved in the antidepressant-like effects of (2R,6R)-hydroxynorketamine in a chronic restraint stress mouse model.
Ju L; Yang J; Zhu T; Liu P; Yang J
BMC Psychiatry; 2022 Mar; 22(1):182. PubMed ID: 35291971
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine.
Shaffer CL; Dutra JK; Tseng WC; Weber ML; Bogart LJ; Hales K; Pang J; Volfson D; Am Ende CW; Green ME; Buhl DL
Neuropharmacology; 2019 Jul; 153():73-81. PubMed ID: 31015046
[TBL] [Abstract][Full Text] [Related]
13. (
Zanos P; Highland JN; Stewart BW; Georgiou P; Jenne CE; Lovett J; Morris PJ; Thomas CJ; Moaddel R; Zarate CA; Gould TD
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6441-6450. PubMed ID: 30867285
[TBL] [Abstract][Full Text] [Related]
14. Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine.
Chen BK; Luna VM; LaGamma CT; Xu X; Deng SX; Suckow RF; Cooper TB; Shah A; Brachman RA; Mendez-David I; David DJ; Gardier AM; Landry DW; Denny CA
Neuropsychopharmacology; 2020 Aug; 45(9):1545-1556. PubMed ID: 32417852
[TBL] [Abstract][Full Text] [Related]
15. cAMP-dependent protein kinase signaling is required for (
Riggs LM; Pereira EFR; Thompson SM; Gould TD
J Neurophysiol; 2024 Jan; 131(1):64-74. PubMed ID: 38050689
[TBL] [Abstract][Full Text] [Related]
16. Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model.
Zhang K; Toki H; Fujita Y; Ma M; Chang L; Qu Y; Harada S; Nemoto T; Mizuno-Yasuhira A; Yamaguchi JI; Chaki S; Hashimoto K
Psychopharmacology (Berl); 2018 Nov; 235(11):3177-3185. PubMed ID: 30215218
[TBL] [Abstract][Full Text] [Related]
17. Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.
Yao N; Skiteva O; Zhang X; Svenningsson P; Chergui K
Mol Psychiatry; 2018 Oct; 23(10):2066-2077. PubMed ID: 29158578
[TBL] [Abstract][Full Text] [Related]
18. (2R,6R)-hydroxynorketamine rapidly potentiates optically-evoked Schaffer collateral synaptic activity.
Riggs LM; Thompson SM; Gould TD
Neuropharmacology; 2022 Aug; 214():109153. PubMed ID: 35661657
[TBL] [Abstract][Full Text] [Related]
19. Topiramate inhibits offensive aggression through targeting ventrolateral periaqueductal gray.
Chou D
Neuropharmacology; 2020 Dec; 181():108361. PubMed ID: 33096107
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant actions of ketamine engage cell-specific translation via eIF4E.
Aguilar-Valles A; De Gregorio D; Matta-Camacho E; Eslamizade MJ; Khlaifia A; Skaleka A; Lopez-Canul M; Torres-Berrio A; Bermudez S; Rurak GM; Simard S; Salmaso N; Gobbi G; Lacaille JC; Sonenberg N
Nature; 2021 Feb; 590(7845):315-319. PubMed ID: 33328636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]